Hence, in this study, to explore whether Sema4A promoted LC development by the PlexinB1-mediated NF-κB pathway, we treated LC cells with various stimulations, and then focused on the biological activity and the expression of the NF-κB pathway, thereby providing a novel target for LC treatment. This evidence concerns the gene SEMA4A and laryngotracheoesophageal cleft.